Table 4 Guideline-adherent CA timing within 24 h contrasting NSTEMI patients with final diagnosis after the first versus the second cTn control
Percentage of CA in time | Overall (%) | Site I (%) | Site II (%) | p value |
|---|---|---|---|---|
NSTEMI ensured by the 1st control (h) | ||||
Overall | 59.1 | 52.5 | 64.6 | 0.76 |
Group (a) | 57.7 | 50.0 | 65.4 | 0.81 |
Group (b) | 62.5 | NA | 62.5 | NA |
Group (c) | 60.0 | 57.1 | 66.7 | 0.90 |
NSTEMI ensured by the 2nd control (h) | ||||
Overall | 62.5 | 50.0 | 66.7 | Omitted to due remaining small sample size |
Group (a) | 66.7 | 50.0 | 75.0 | |
Group (b) | 50.0 | NA | 50.0 | |
Group (c) | – | – | NA | |